Friday 6-13-2014 Horizon Pharma Inc (HZNP) $HZNP opened at 14.74 hitting the high price of 14.89 and a day low of 14.23 with a total volume of 1,064,716. HZNP had a previous close of 14.71 and has been seeing an average volume of 1,898,565.
Overall Average: 72% Buy
Recent stock forum discussions about HZNP http://investorshangout.com/search?q=HZNP&...mp;yt0=Go!
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI
PR Newswire - Thu Jun 12, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Forest Laboratories, Inc. (NYSE: FRX), Intuitive Surgical, Inc. (NASDAQ: ISRG), Horizon Pharma Inc (NASDAQ: HZNP), Cubist Pharmaceuticals Inc (NASDAQ: CBST) and BioDelivery Sciences International, Inc. (NASDAQ: BDSI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3640-100free. (full story)
Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 7:35AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Horizon Pharma’s earnings for the coming quarter and year. (full story)
Horizon Pharma awards inducement grants to five new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Mon Jun 09, 6:25AM CDT
Pharmaceutical company Pharma (NASDAQ:HZNP) said on Friday that the board of directors' compensation committee granted inducement awards to five new employees entering into employment in accordance with NASDAQ Listing Rule 5635(c)(4). (full story)
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Fri Jun 06, 3:45PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on June 6, 2014 the Compensation Committee of its Board of Directors granted inducement awards to five new employees. (full story)
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 8:42AM CDT
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? (full story)
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 29, 7:57AM CDT
Horizon Pharma (HZNP) looks well positioned for a solid gain, but has been overlooked by investors lately. This stock has actually seen estimates rise over the past month for the current fiscal year by about 34.7%. (full story)
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint
PR Newswire - Wed May 28, 5:17AM CDT
The US markets saw a positive sentiment on Tuesday, May 27, 2014, with the NASDAQ Composite closing at 4,237.07, up 1.22%, the Dow Jones Industrial Average ending the session at 16,675.50, up 0.42% and the S&P 500 finishing 0.60% higher at 1,911.91. The gains were broad based as nine out of ten sectors finished on a higher note. A number of stocks saw large movements, including Horizon Pharma Inc. (NASDAQ: HZNP), Celldex Therapeutics Inc. (NASDAQ: CLDX), Extreme Networks Inc. (NASDAQ: EXTR) and WidePoint Corp. (NYSE MKT: WYY). Free technical research on HZNP, CLDX, EXTR and WYY can be downloaded upon signing up at: (full story)
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference
Marketwire - Tue May 27, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 3:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities. (full story)
Horizon Pharma awards inducement stock options to six new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Mon May 26, 3:24AM CDT
The compensation committee of the board of directors of Horizon Pharma (NASDAQ:HZNP), a pharmaceutical company, reported on Friday the grant of stock options to purchase an aggregate of 21,000 shares of its common stock to six new employees. (full story)
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
PR Newswire - Fri May 16, 6:20AM CDT
Today, Analysts Review released its analysts' notes regarding Zoetis Inc. (NYSE: ZTS), Horizon Pharma, Inc. (NASDAQ: HZNP), Akorn, Inc. (NASDAQ: AKRX), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2536-100free. (full story)
Horizon guides '14 sales up
at Investor's Business Daily - Fri May 09, 6:25PM CDT
The specialty drugmaker swung to a Q1 profit of 13 cents a share from a year-earlier loss of 36 cents. Analysts expected Horizon Pharma (HZNP) to make 1 cent. Sales soared to $51.9 mil up from $8.7 mil, topping views, on sales of arthritis painkiller... (full story)
Horizon Pharma Q1 Beats Street; Guidance Mixed
at Investor's Business Daily - Fri May 09, 10:12AM CDT
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q1 estimates and raised its sales guidance Friday morning, briefly rallying the stock on the stock market today. Horizon reported its first quarterly profit, excluding one-time items, making 13... (full story)
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance
Marketwire - Fri May 09, 5:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for the first quarter ended March 31, 2014. (full story)
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 6:18AM CDT
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? (full story)
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co
PR Newswire - Wed Apr 30, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Mylan, Inc. (NASDAQ: MYL), Zoetis Inc. (NYSE: ZTS), Hospira Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP) and The Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1816-100free. (full story)
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014
Marketwire - Fri Apr 25, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its first quarter 2014 financial results will be released on Friday, May 9, 2014. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update. (full story)
Horizon Pharma awards inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4)
M2 - Thu Apr 24, 5:03AM CDT
Pharmaceutical company Horizon Pharma (NASDAQ:HZNP) on Wednesday granted stock options to ten new non-executive employees to purchase up to 76,500 shares of its common stock. (full story)
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
PR Newswire - Wed Apr 23, 10:34AM CDT
On Tuesday, April 22, 2014, the NASDAQ Composite ended at 4,161.46, up 0.97%, the Dow Jones Industrial Average finished the session 0.40% higher at 16,514.37, and the S&P 500 closed at 1,879.55, up 0.41%. The gains were broad based as eight out of ten sectors finished on a higher note. A number of stocks saw large movements, including Centene Corp. (NYSE: CNC), Prana Biotechnology Ltd (NASDAQ: PRAN), Horizon Pharma Inc. (NASDAQ: HZNP) and Scientific Games Corp. (NASDAQ: SGMS). Free technical research on CNC, PRAN, HZNP and SGMS can be downloaded upon signing up at: (full story)
Overall Average: 72% Buy
Recent stock forum discussions about HZNP http://investorshangout.com/search?q=HZNP&...mp;yt0=Go!
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI
PR Newswire - Thu Jun 12, 5:10AM CDT
Today, Analysts Review released its analysts' notes regarding Forest Laboratories, Inc. (NYSE: FRX), Intuitive Surgical, Inc. (NASDAQ: ISRG), Horizon Pharma Inc (NASDAQ: HZNP), Cubist Pharmaceuticals Inc (NASDAQ: CBST) and BioDelivery Sciences International, Inc. (NASDAQ: BDSI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3640-100free. (full story)
Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 11, 7:35AM CDT
Positive earnings estimate revisions suggest that analysts are becoming more optimistic on Horizon Pharma’s earnings for the coming quarter and year. (full story)
Horizon Pharma awards inducement grants to five new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Mon Jun 09, 6:25AM CDT
Pharmaceutical company Pharma (NASDAQ:HZNP) said on Friday that the board of directors' compensation committee granted inducement awards to five new employees entering into employment in accordance with NASDAQ Listing Rule 5635(c)(4). (full story)
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Fri Jun 06, 3:45PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on June 6, 2014 the Compensation Committee of its Board of Directors granted inducement awards to five new employees. (full story)
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 02, 8:42AM CDT
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? (full story)
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 29, 7:57AM CDT
Horizon Pharma (HZNP) looks well positioned for a solid gain, but has been overlooked by investors lately. This stock has actually seen estimates rise over the past month for the current fiscal year by about 34.7%. (full story)
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint
PR Newswire - Wed May 28, 5:17AM CDT
The US markets saw a positive sentiment on Tuesday, May 27, 2014, with the NASDAQ Composite closing at 4,237.07, up 1.22%, the Dow Jones Industrial Average ending the session at 16,675.50, up 0.42% and the S&P 500 finishing 0.60% higher at 1,911.91. The gains were broad based as nine out of ten sectors finished on a higher note. A number of stocks saw large movements, including Horizon Pharma Inc. (NASDAQ: HZNP), Celldex Therapeutics Inc. (NASDAQ: CLDX), Extreme Networks Inc. (NASDAQ: EXTR) and WidePoint Corp. (NYSE MKT: WYY). Free technical research on HZNP, CLDX, EXTR and WYY can be downloaded upon signing up at: (full story)
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference
Marketwire - Tue May 27, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Jefferies 2014 Global Healthcare Conference on Monday, June 2, 2014 at 3:30 p.m. Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities. (full story)
Horizon Pharma awards inducement stock options to six new employees under NASDAQ Listing Rule 5635(c)(4)
M2 - Mon May 26, 3:24AM CDT
The compensation committee of the board of directors of Horizon Pharma (NASDAQ:HZNP), a pharmaceutical company, reported on Friday the grant of stock options to purchase an aggregate of 21,000 shares of its common stock to six new employees. (full story)
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
PR Newswire - Fri May 16, 6:20AM CDT
Today, Analysts Review released its analysts' notes regarding Zoetis Inc. (NYSE: ZTS), Horizon Pharma, Inc. (NASDAQ: HZNP), Akorn, Inc. (NASDAQ: AKRX), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2536-100free. (full story)
Horizon guides '14 sales up
at Investor's Business Daily - Fri May 09, 6:25PM CDT
The specialty drugmaker swung to a Q1 profit of 13 cents a share from a year-earlier loss of 36 cents. Analysts expected Horizon Pharma (HZNP) to make 1 cent. Sales soared to $51.9 mil up from $8.7 mil, topping views, on sales of arthritis painkiller... (full story)
Horizon Pharma Q1 Beats Street; Guidance Mixed
at Investor's Business Daily - Fri May 09, 10:12AM CDT
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q1 estimates and raised its sales guidance Friday morning, briefly rallying the stock on the stock market today. Horizon reported its first quarterly profit, excluding one-time items, making 13... (full story)
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance
Marketwire - Fri May 09, 5:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for the first quarter ended March 31, 2014. (full story)
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 6:18AM CDT
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? (full story)
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co
PR Newswire - Wed Apr 30, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Mylan, Inc. (NASDAQ: MYL), Zoetis Inc. (NYSE: ZTS), Hospira Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP) and The Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1816-100free. (full story)
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014
Marketwire - Fri Apr 25, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its first quarter 2014 financial results will be released on Friday, May 9, 2014. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update. (full story)
Horizon Pharma awards inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4)
M2 - Thu Apr 24, 5:03AM CDT
Pharmaceutical company Horizon Pharma (NASDAQ:HZNP) on Wednesday granted stock options to ten new non-executive employees to purchase up to 76,500 shares of its common stock. (full story)
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
PR Newswire - Wed Apr 23, 10:34AM CDT
On Tuesday, April 22, 2014, the NASDAQ Composite ended at 4,161.46, up 0.97%, the Dow Jones Industrial Average finished the session 0.40% higher at 16,514.37, and the S&P 500 closed at 1,879.55, up 0.41%. The gains were broad based as eight out of ten sectors finished on a higher note. A number of stocks saw large movements, including Centene Corp. (NYSE: CNC), Prana Biotechnology Ltd (NASDAQ: PRAN), Horizon Pharma Inc. (NASDAQ: HZNP) and Scientific Games Corp. (NASDAQ: SGMS). Free technical research on CNC, PRAN, HZNP and SGMS can be downloaded upon signing up at: (full story)
